6533b834fe1ef96bd129e075
RESEARCH PRODUCT
Early Sacubitril/Valsartan-driven Benefit on Exercise Capacity in Heart Failure With Reduced Ejection Fraction: A Pilot Study
Eloy DomínguezAnna MollarPatricia PalauJulio NúñezAntoni Bayes-genisJuan Sanchissubject
Malemedicine.medical_specialtyTreatment outcomeTetrazolesPilot Projects030204 cardiovascular system & hematology030226 pharmacology & pharmacyAngiotensin Receptor Antagonists03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansNeprilysinAgedHeart FailureExercise ToleranceEjection fractionbusiness.industryAminobutyratesBiphenyl CompoundsStroke VolumeGeneral MedicineExercise capacitymedicine.diseaseDrug CombinationsTreatment OutcomeHeart failureCardiologyValsartanFemaleNeprilysinbusinessSacubitril Valsartanyear | journal | country | edition | language |
---|---|---|---|---|
2017-08-09 | Revista Española de Cardiología (English Edition) |